Freeport-McMoran Copper & Gold Inc (FCX)vsSanofi ADR (SNY)
FCX
Freeport-McMoran Copper & Gold Inc
$61.65
+1.72%
BASIC MATERIALS · Cap: $88.62B
SNY
Sanofi ADR
$43.31
+0.30%
HEALTHCARE · Cap: $103.45B
Smart Verdict
WallStSmart Research — data-driven comparison
Sanofi ADR generates 79% more annual revenue ($47.35B vs $26.42B). SNY leads profitability with a 16.0% profit margin vs 10.3%. SNY appears more attractively valued with a PEG of 3.76. FCX earns a higher WallStSmart Score of 64/100 (C+).
FCX
Buy64
out of 100
Grade: C+
SNY
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-36.5%
Fair Value
$47.94
Current Price
$61.65
$13.71 premium
Margin of Safety
+24.9%
Fair Value
$62.64
Current Price
$43.31
$19.33 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 154.0% YoY
Large-cap with strong market position
Strong operational efficiency at 23.1%
Reasonable price relative to book value
Large-cap with strong market position
Strong operational efficiency at 20.0%
Generating 1.7B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Distress zone — elevated risk
Weak financial health signals
Expensive relative to growth rate
ROE of 6.6% — below average capital efficiency
Expensive relative to growth rate
Earnings declined 11.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : FCX
The strongest argument for FCX centers on EPS Growth, Market Cap, Operating Margin.
Bull Case : SNY
The strongest argument for SNY centers on Price/Book, Market Cap, Operating Margin. Profitability is solid with margins at 16.0% and operating margin at 20.0%.
Bear Case : FCX
The primary concerns for FCX are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : SNY
The primary concerns for SNY are Return on Equity, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
FCX profiles as a value stock while SNY is a mature play — different risk/reward profiles.
FCX carries more volatility with a beta of 1.32 — expect wider price swings.
FCX is growing revenue faster at 8.8% — sustainability is the question.
SNY generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
FCX scores higher overall (64/100 vs 51/100). SNY offers better value entry with a 24.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Freeport-McMoran Copper & Gold Inc
BASIC MATERIALS · COPPER · USA
Freeport-McMoRan Inc., often called Freeport, is an American mining company based in the Freeport-McMoRan Center, in Phoenix, Arizona.
Visit Website →Sanofi ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?